Table of contents

Extended reports

• Involvement of neurotrophins and their receptors in spondyloarthritis synovitis: relation to inflammation and response to treatment (7 April, 2005)

  M Rihl, E Kruithof, C Barthel, F De Keyser, E M Veys, H Zeidler, D T Y Yu, J G Kuipers, D Baeten
• Tumour necrosis factor receptor gene therapy affects cellular immune responses in collagen induced arthritis in mice (28 April, 2005)

  P Mukherjee, S-Y Yang, B Wu, Z Song, L K Myers, P D Robbins, P H Wooley
• Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks (20 April, 2005)

  J C Davis, D M van der Heijde, J Braun, M Dougados, J Cush, D Clegg, R D Inman, A Kivitz, L Zhou, A Solinger, W Tsuji
• Efficacy of cyclo-oxygenase-2 inhibition by etoricoxib and naproxen on the axial manifestations of ankylosing spondylitis in the presence of peripheral arthritis (24 February, 2005)

  L Gossec, D van der Heijde, A Melian, D A Krupa, M K James, P F Cavanaugh, A S Reicin, M Dougados
• Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study (13 April, 2005)

  H Marzo-Ortega, D McGonagle, S Jarrett, G Haugeberg, E Hensor, P O’Connor, A L Tan, P G Conaghan, A Greenstein, P Emery
• ICF based comparison of disease specific instruments measuring physical functional ability in ankylosing spondylitis (20 April, 2005)

  T Sigl, A Cieza, D van der Heijde, G Stucki
• Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results (28 April, 2005)

  D van der Heijde, L Klareskog, M Boers, R Landewé, C Codreanu, H D Bolosiu, R Pedersen, S Fatenejad
• Socioeconomic status and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study (20 April, 2005)

  C Bengtsson, B Nordmark, L Klareskog, I Lundberg, L Alfredsson
• Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s (20 April, 2005)

  N Goodson, J Marks, M Lunt, D Symmons
• Occurrence and risk factors for falls in rheumatoid arthritis (7 April, 2005)

  C Armstrong, C M Swarbrick, S R Pye, T W O’Neill
• Differential effect of IL10 and TNFα genotypes on determining susceptibility to discoid and systemic lupus erythematosus (30 March, 2005)

  A Suárez, P López, L Mozo, C Gutiérrez
• Oestrogen receptor α gene polymorphisms in systemic lupus erythematosus (7 April, 2005)

  M Johansson, L Ärlestig, B Möller, T Smedby, S Rantapää-Dahlqvist
• Improvement of coping abilities in patients with systemic lupus erythematosus: a prospective study (13 April, 2005)

  M Haupt, S Millen, M Jänner, D Falagan, R Fischer-Betz, M Schneider
• Oncostatin M in combination with tumour necrosis factor α induces a chondrocyte membrane associated aggrecanase that is distinct from ADAMTS aggrecanase-1 or -2 (5 May, 2005)

  W Hui, H E Barksby, D A Young, T E Cawston, N McKie, A D Rowan
• Activity limitations and participation restrictions in women with hand osteoarthritis: patients’ descriptions and associations between dimensions of functioning (13 April, 2005)

  I Kjeken, H Dagfinrud, B Slatkowsky-Christensen, P Mowinckel, T Uhlig, T K Kvien, A Finset
• Antiphospholipid antibody tests: spreading the net (7 April, 2005)

  M L Bertolaccini, S Gomez, J F P Pareja, A Theodoridou, G Sanna, G R V Hughes, M A Khamashta